GALEAS® Hereditary

Hereditary Cancer Direct

Hereditary Cancer Direct is our GALEAS® Hereditary testing service, designed specifically for patients who wish to understand their risk of inherited cancer. Patients can self-refer or be referred by a clinician, and are supported throughout by an expert genetic counsellor.

UKAS Accreditation Symbol
CQC

Nonacus Clinical Services has partnered with Gene Care to deliver this service. Each patient is supported by one of Gene Care's expert genetic counsellors before and after testing.

nonacus-clinical-services_w
Gene Care w

Find out more and start your journey

We have a dedicated website where patients can learn about the Hereditary Cancer Direct service, understand the testing process, and book their test directly. A genetic counsellor will guide them through every step.

Visit the Hereditary Cancer Direct website

What our patients say

Arlene Rose is 69 and received a positive test earlier this year after joining the NHS BRCA Screening programme.

In November 2023, my daughter-in-law sent me a WhatsApp message linking to the NHS BRCA Screening programme stating, ‘I am getting tested, are you?

The test arrived promptly, and I sent it off in early December without a second thought. So, it was a huge shock to open the results letter in early January to find out that I had the BRCA gene mutation that could lead to several cancers, including ovarian.